Joseph C. Maroon
President at Inflammation Solutions LLC
Joseph C. Maroon active positions
Companies | Position | Start | End |
---|---|---|---|
The American Academy of Anti-Aging Medicine, Inc.
The American Academy of Anti-Aging Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services The American Academy of Anti-Aging Medicine, Inc. operates as a nonprofit organization that promotes the field of anti-aging medicine and trains and certifies physicians in this specialty. It engages in the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process. The company was founded by Ronald M. Klatz and Robert M. Goldman in 1992 and is headquartered in Boca Raton, FL. | Corporate Officer/Principal | - | - |
Inflammation Solutions LLC | President | - | - |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Director/Board Member | - | - |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Director/Board Member | - | - |
Career history of Joseph C. Maroon
Former positions of Joseph C. Maroon
Companies | Position | Start | End |
---|---|---|---|
CV SCIENCES, INC. | Director/Board Member | 2018-08-05 | 2022-07-20 |
Independent Dir/Board Member | 2018-08-05 | 2022-07-20 | |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director/Board Member | 2002-12-31 | 2017-06-21 |
Independent Dir/Board Member | 2002-12-31 | 2017-06-21 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Director/Board Member | 2004-12-31 | 2016-12-31 |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Director/Board Member | 2002-12-31 | 2016-12-31 |
Independent Dir/Board Member | 2011-07-13 | 2016-12-31 | |
Allegheny General Hospital, Inc.
Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Corporate Officer/Principal | 1998-12-31 | 1998-12-31 |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░ ░░░░░░░░ ░░░░ ░ ░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Joseph C. Maroon
Indiana University | Undergraduate Degree |
Statistics
International
United States | 15 |
United Kingdom | 2 |
Operational
Director/Board Member | 8 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sectoral
Health Technology | 7 |
Health Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CV SCIENCES, INC. | Health Technology |
Private companies | 13 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
University of Pittsburgh Medical Center
University of Pittsburgh Medical Center Medical/Nursing ServicesHealth Services University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA. | Health Services |
Allegheny General Hospital, Inc.
Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Health Services |
The American Academy of Anti-Aging Medicine, Inc.
The American Academy of Anti-Aging Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services The American Academy of Anti-Aging Medicine, Inc. operates as a nonprofit organization that promotes the field of anti-aging medicine and trains and certifies physicians in this specialty. It engages in the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process. The company was founded by Ronald M. Klatz and Robert M. Goldman in 1992 and is headquartered in Boca Raton, FL. | Commercial Services |
Congress of Neurological Surgeons | |
American Youth Foundation | |
Think First National Head & Neck Injury Prevention Society | |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Inflammation Solutions LLC | |
ImPACT Applications, Inc.
ImPACT Applications, Inc. Packaged SoftwareTechnology Services ImPACT Applications, Inc. engages in the provision of concussion management solutions. Its products include ImPACT pediatric, ImPACT quick test, ImPACT passport, and ImPACT toolkit. The company was founded by Mark Lovell, Michael Collins, and Joseph Maroon in 2002 and is headquartered in Coralville, IA. | Technology Services |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Joseph C. Maroon
- Experience